Challenges and Opportunities for Quantitative Clinical Pharmacology in Cancer Immunotherapy: Something Old, Something New, Something Borrowed, and Something Blue

Publisher： John Wiley & Sons Inc

E-ISSN： 2163-8306|2163-8306|9|495-497

ISSN： 2163-8306

Source： Cpt: Pharmacometrics & Systems Pharmacology, Vol.2163-8306, Iss.9, 2015-09, pp. : 495-497

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Challenges and Opportunities for Quantitative Clinical Pharmacology in Cancer Immunotherapy: Something Old, Something New, Something Borrowed, and Something Blue

By  

Cpt: Pharmacometrics & Systems Pharmacology, Vol. 4, Iss. 9, 2015-09 ,pp. : 495-497

John Wiley & Sons Inc

Access to resources Recommend Favorite

GRK2 Inhibition in Heart Failure: Something Old, Something New

By  

Current Pharmaceutical Design, Vol. 18, Iss. 2, 2012-01 ,pp. : 186-191

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Perioperative Organoprotection, Something New and Something Wrong.

By  

Current Pharmaceutical Design, Vol. 20, Iss. 34, 2014-01 ,pp. : 5448-5448

Bentham Science Publishers

Access to resources Recommend Favorite

Thiopurines in Crohn's disease, is there something new?

By Miheller Pal   Lakatos Peter Laszlo  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1505-1514

Informa Healthcare

Access to resources Recommend Favorite

Migraine prophylactic drugs –– something new under the sun?

By Bekkelund Svein I   Alstadhaug Karl B  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 9, 2011-09 ,pp. : 1201-1210

Informa Healthcare

Access to resources Recommend Favorite